Garlic tablets to prevent infections in ICU patients
Part of Infections clinical trials.
This trial tests whether garlic tablets can help prevent hospital-acquired infections in ICU patients. It may be an option for adults in the ICU who do not currently have an infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You are currently admitted to the intensive care unit (ICU).
- You do not have any signs of infection right now.
- You do not have HIV, cancer, or recent use of strong immune-suppressing drugs or steroids.
- You do not have a bleeding disorder or abnormal blood clotting.
- You are not scheduled for surgery within the next 2 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether probiotics (good bacteria) can help prevent serious infections in critically ill patients in the ICU. If you are very sick and in the ICU, you may be able to join — as long as you don't have certain conditions like cancer or a weakened immune system.
This trial tests a new device that measures antibiotic levels in blood quickly at the bedside, so doctors can adjust your dose to make sure it's effective. It may help ICU patients on beta-lactam antibiotics get the right amount.
This trial tests whether giving vancomycin through a tube into the stomach can prevent a serious gut infection called C. diff in people who are very sick in the ICU and taking antibiotics. If you qualify, you might receive this medicine to lower your risk.
This study looks at how having a weakened immune system affects the risk of getting infections with hard-to-treat bacteria in the ICU. Depending on your immune status, you may be placed in a group that helps doctors understand who is most at risk.
This trial tests an experimental drug called Fluorothiazinone to prevent serious bacterial infections in ICU patients who are on a breathing machine (ventilator) or likely to need one soon. It includes patients with COVID-19 pneumonia, stroke, or heart failure.
This trial tests if a drug called interferon gamma can help prevent new infections in ICU patients with a weakened immune system. It may help people who have been in the ICU for at least a week and have had multiple organ failure.
Hear when a new Nosocomial Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.